Summary & Overview
CPT 48400: Intraoperative Pancreatic Duct Contrast Study
CPT code 48400 represents the intraoperative injection of contrast into the pancreatic duct for radiographic imaging to assess ductal patency and rule out obstruction during pancreatic surgery. This targeted diagnostic step informs surgical decision-making and can influence immediate intraoperative management to prevent postoperative complications related to ductal obstruction.
Key payers in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis covers clinical context, coding considerations, and payer coverage patterns relevant to hospitals, surgical teams, and billing departments.
Readers will gain an understanding of the clinical purpose of CPT code 48400, the typical care setting (operating room during pancreatic surgery), and the types of surgical scenarios where the code applies. The publication outlines common billing modifiers associated with intraoperative diagnostic procedures, summarizes payer coverage approaches, and highlights benchmarks and policy updates affecting reimbursement and documentation expectations. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 48400 describes the injection of a radiographic dye into the pancreatic duct to obtain X-ray imaging of the ductal system during pancreatic surgery. This procedure is performed intraoperatively to evaluate patency and detect obstruction of pancreatic fluid flow.
-
Service type: Intraoperative diagnostic imaging procedure involving contrast injection into the pancreatic duct
-
Typical site of service: Operating room during pancreatic surgical procedures
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult undergoing an open or exploratory pancreatic operation — for example, a distal pancreatectomy, pancreatic head resection, or repair of a traumatic pancreatic duct injury. The patient often presents with symptoms or imaging findings consistent with obstructive pancreatopathy, suspected pancreatic duct disruption, chronic pancreatitis with ductal strictures, or intraoperative concern for retained ductal obstruction. Intraoperatively, after exposure of the pancreas, the surgeon cannulates the pancreatic duct and injects radiopaque contrast dye under fluoroscopy to perform a pancreatogram. The imaging confirms ductal patency, identifies strictures or leaks, and guides further operative steps such as ductal repair, pancreaticojejunostomy, stricture dilation, or additional resection. Typical site of service is an operating room in an acute care hospital; the service is physician‑performed, generally by a general surgeon or hepatopancreatobiliary (HPB) surgeon, often with intraoperative radiology/fluoroscopy support and perioperative anesthesia care. Patient monitoring includes standard intraoperative vital signs, fluoroscopic imaging, and documentation of contrast type, volume, and duct cannulation technique.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal or initial procedural service | Use when the surgeon performs the procedure as the primary service during the operative session. |